萝莉乱伦

Hao Zhang is a seasoned professional in the pharmaceutical and biotechnology industries with extensive experience in corporate development and clinical research. Currently serving as the Head of Corporate Development at 3SBio Inc. since March 2022, Zhang has previously held key positions at notable companies, including Chief Development Officer at SinoMab Bioscience Ltd. and Global Clinical Development Strategy Lead for China/APAC at Baxter International Inc. Zhang's career also includes significant roles at Pfizer, Sanofi, Johnson & Johnson R&D, and C-Bridge Capital, showcasing expertise in regional medical leadership and clinical research. Educational credentials include a Dr.med degree from the University of Zurich, an M.Sc. from KU Leuven, and two degrees from Zhejiang University.